JP2009286793A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009286793A5 JP2009286793A5 JP2009202035A JP2009202035A JP2009286793A5 JP 2009286793 A5 JP2009286793 A5 JP 2009286793A5 JP 2009202035 A JP2009202035 A JP 2009202035A JP 2009202035 A JP2009202035 A JP 2009202035A JP 2009286793 A5 JP2009286793 A5 JP 2009286793A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- composition according
- tweak
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37161102P | 2002-04-09 | 2002-04-09 | |
| US60/371,611 | 2002-04-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583337A Division JP2005536455A (ja) | 2002-04-09 | 2003-04-09 | Ｔｗｅａｋ関連状態を治療するための方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011196571A Division JP2012021014A (ja) | 2002-04-09 | 2011-09-08 | Ｔｗｅａｋ関連状態を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009286793A JP2009286793A (ja) | 2009-12-10 |
| JP2009286793A5 true JP2009286793A5 (https=) | 2011-02-17 |
| JP5603040B2 JP5603040B2 (ja) | 2014-10-08 |
Family
ID=29250708
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583337A Pending JP2005536455A (ja) | 2002-04-09 | 2003-04-09 | Ｔｗｅａｋ関連状態を治療するための方法 |
| JP2009202035A Expired - Fee Related JP5603040B2 (ja) | 2002-04-09 | 2009-09-01 | Ｔｗｅａｋ関連状態を治療するための方法 |
| JP2011196571A Withdrawn JP2012021014A (ja) | 2002-04-09 | 2011-09-08 | Ｔｗｅａｋ関連状態を治療するための方法 |
| JP2014016608A Expired - Fee Related JP5916776B2 (ja) | 2002-04-09 | 2014-01-31 | Ｔｗｅａｋ関連状態を治療するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583337A Pending JP2005536455A (ja) | 2002-04-09 | 2003-04-09 | Ｔｗｅａｋ関連状態を治療するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011196571A Withdrawn JP2012021014A (ja) | 2002-04-09 | 2011-09-08 | Ｔｗｅａｋ関連状態を治療するための方法 |
| JP2014016608A Expired - Fee Related JP5916776B2 (ja) | 2002-04-09 | 2014-01-31 | Ｔｗｅａｋ関連状態を治療するための方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US20060240004A1 (https=) |
| EP (4) | EP1494713A4 (https=) |
| JP (4) | JP2005536455A (https=) |
| KR (2) | KR101000842B1 (https=) |
| CN (5) | CN1658901A (https=) |
| AU (1) | AU2003224950B2 (https=) |
| BR (1) | BRPI0309126A8 (https=) |
| CA (2) | CA2887716C (https=) |
| DK (1) | DK1997512T3 (https=) |
| EA (1) | EA011607B1 (https=) |
| ES (1) | ES2444121T3 (https=) |
| IL (3) | IL164352A0 (https=) |
| MX (2) | MX352180B (https=) |
| NO (2) | NO334266B1 (https=) |
| NZ (2) | NZ536348A (https=) |
| PT (1) | PT1997512E (https=) |
| SI (1) | SI1997512T1 (https=) |
| WO (1) | WO2003086311A2 (https=) |
| ZA (1) | ZA200408073B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7129061B1 (en) * | 1996-08-07 | 2006-10-31 | Biogen Idec Ma Inc. | Tumor necrosis factor related ligand |
| MXPA01007163A (es) * | 1999-01-15 | 2002-03-27 | Biogen Inc | Antagonistas de tweak y de receptores de tweak y su uso para tratar trastornos inmunologicos. |
| AU5951901A (en) | 2000-05-08 | 2001-11-20 | Biogen Inc | Method for promoting neovascularization |
| US7208151B2 (en) | 2001-09-12 | 2007-04-24 | Biogen Idec Ma Inc. | Tweak receptor agonists as anti-angiogenic agents |
| MX352180B (es) | 2002-04-09 | 2017-11-13 | Biogen Ma Inc | El uso de antagonistas de tweak para el tratamiento de condiciones relacionadas con tweak. |
| WO2005053728A2 (de) * | 2003-12-01 | 2005-06-16 | Xantos Biomedicine Ag | Mit adipositas assoziierte proteine und deren verwendung in therapie und diagnostik |
| US7939490B2 (en) * | 2004-12-13 | 2011-05-10 | University Of Maryland, Baltimore | TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death |
| AU2011239311B2 (en) * | 2005-02-17 | 2014-05-22 | Biogen Ma Inc. | Treating Neurological Disorders |
| US20090068102A1 (en) * | 2005-02-17 | 2009-03-12 | Biogen Idec Ma Inc. | Treating stroke |
| WO2006089095A2 (en) * | 2005-02-17 | 2006-08-24 | Biogen Idec Ma Inc. | Treating neurological disorders |
| CA2607697C (en) | 2005-05-10 | 2015-01-06 | Biogen Idec Ma Inc. | Treating and evaluating inflammatory disorders |
| EP1764109A1 (de) * | 2005-05-24 | 2007-03-21 | Xantos Biomedicine AG | Agonistische Antikörper, welche an den Tweak Rezeptor Fn14 binden und dadurch Adipositas assoziierte Phänotypen modulieren, und deren Verwendung in der Therapie |
| WO2006125632A2 (en) * | 2005-05-24 | 2006-11-30 | Rechtsanwalt Dr. Martin Prager Als Insolvenzverwalter Über Das Vermögen Der Xantos Biomedicine Ag, Pluta Rechtsanwalts Gmbh | Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| MEP35408A (en) | 2005-05-27 | 2011-02-10 | Biogen Idec Inc | Tweak binding antibodies |
| WO2006130429A2 (en) * | 2005-05-27 | 2006-12-07 | Biogen Idec Ma Inc. | Treatment of cancer |
| WO2006138219A2 (en) | 2005-06-13 | 2006-12-28 | Biogen Idec Ma Inc. | Methods of diagnosis / prognosis of inflammatory conditions |
| CA2729351C (en) | 2008-06-30 | 2017-01-24 | University Of Pennsylvania | Fn14/trail fusion proteins |
| WO2010019234A1 (en) * | 2008-08-12 | 2010-02-18 | Ihc Intellectual Asset Management, Llc | Analysis of genetic markers for peripartum cardiomyopathy |
| JP5161718B2 (ja) * | 2008-09-25 | 2013-03-13 | 株式会社ゲノム創薬研究所 | 肝障害モデル動物、及びそれを用いた肝障害を改善又は予防する、薬剤若しくは食品素材のスクリーニング方法 |
| MX2011007936A (es) * | 2009-01-30 | 2011-08-17 | Biogen Idec Inc | Metodos para regeneracion de tejido pancreatico. |
| US8093006B2 (en) | 2009-04-02 | 2012-01-10 | Hoffmann-La Roche Inc. | Antibodies against human tweak and uses thereof |
| US9096879B2 (en) * | 2009-11-24 | 2015-08-04 | Biogen Ma Inc. | Method of supplementing culture media to prevent undesirable amino acid substitutions |
| US9068004B2 (en) | 2010-02-04 | 2015-06-30 | University Of Louisville Research Foundation, Inc. | TWEAK/Fn14 system regulates skeletal muscle atrophy and regeneration |
| AU2011309689B2 (en) | 2010-09-28 | 2015-01-15 | Hadasit Medical Research Services & Development Ltd. | Compositions and methods for treatment of hematological malignancies |
| AU2011311673B2 (en) | 2010-10-05 | 2015-09-17 | F. Hoffmann-La Roche Ag | Antibodies against human TWEAK and uses thereof |
| RU2462222C1 (ru) * | 2011-07-11 | 2012-09-27 | Наталья Николаевна Молчанова | Способ лечения больных артериальной гипертонией с метаболическими нарушениями |
| HK1198832A1 (en) * | 2011-08-23 | 2015-06-12 | Transbio Ltd | Fn14 binding proteins and uses thereof |
| WO2013150043A1 (en) | 2012-04-05 | 2013-10-10 | F. Hoffmann-La Roche Ag | Bispecific antibodies against human tweak and human il17 and uses thereof |
| GB201317929D0 (en) * | 2013-10-10 | 2013-11-27 | Ucl Business Plc | Chimeric antigen receptor |
| CA2958585C (en) * | 2014-08-21 | 2024-01-09 | Stealth Biotherapeutics Corp | Use of peptide d-arg-2',6'-dmt-lys-phe-nh2 for the treatment of alport syndrome |
| AU2015336946A1 (en) * | 2014-10-23 | 2017-04-13 | La Trobe University | Fn14-binding proteins and uses thereof |
| KR101881531B1 (ko) * | 2016-11-25 | 2018-07-25 | 고려대학교 산학협력단 | 폴리-2-하이드록시에틸 메타아크릴레이트를 이용한 사이토카인의 발현능이 증가된 줄기세포의 제조방법 |
| AU2021331368A1 (en) * | 2020-08-28 | 2023-03-16 | Resolution Therapeutics Limited | Modified immune cells for fibrosis and inflammation |
| CN113616777A (zh) * | 2021-08-18 | 2021-11-09 | 中山大学附属第三医院（中山大学肝脏病医院） | 基于主要尿蛋白改善内质网应激的转化应用 |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| US5200313A (en) | 1983-08-05 | 1993-04-06 | Miles Inc. | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
| US4921698A (en) | 1984-05-25 | 1990-05-01 | Asahi Kasei Kogyo Kabushiki Kaisha | Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4 |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| DE122007000007I2 (de) | 1986-04-09 | 2010-12-30 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| US5073492A (en) | 1987-01-09 | 1991-12-17 | The Johns Hopkins University | Synergistic composition for endothelial cell growth |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| AT396939B (de) | 1990-05-29 | 1993-12-27 | Alois Dipl Ing Dr Jungbauer | Komplexes virales antigen von hiv-1 bindendes rekombinantes protein |
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| JPH05244982A (ja) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| EP0679716A4 (en) | 1993-11-12 | 1999-06-09 | Kenichi Matsubara | GENE SIGNATURE. |
| US20030198640A1 (en) | 1994-11-07 | 2003-10-23 | Human Genome Sciences, Inc. | Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta |
| US6544761B2 (en) | 1994-12-13 | 2003-04-08 | Human Genome Sciences, Inc. | Human tissue inhibitor of metalloproteinase-4 |
| ES2281898T3 (es) | 1994-12-13 | 2007-10-01 | Human Genome Sciences, Inc. | Inhibidor tisular humano de metaloproteinasa-4. |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
| CZ297387B6 (cs) | 1996-08-07 | 2006-11-15 | Biogen Idec Ma Inc. | Sekvence DNA kódující ligand príbuzný TNF, polypeptid a zpusob jeho prípravy, protilátka reaktivní s polypeptidem a farmaceutická kompozice |
| US7129061B1 (en) | 1996-08-07 | 2006-10-31 | Biogen Idec Ma Inc. | Tumor necrosis factor related ligand |
| US5858991A (en) | 1997-01-29 | 1999-01-12 | Vanderbilt University | Facilitation of wound healing with CM101/GBS toxin |
| CA2280231A1 (en) * | 1997-02-12 | 1998-08-13 | Abbott Laboratories | Member of the tnf family useful for treatment and diagnosis of disease |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| AU7549498A (en) | 1997-06-03 | 1998-12-21 | Protegene Inc. | Human proteins having transmembrane domains and dnas encoding these prot eins |
| WO1999011791A2 (en) | 1997-09-05 | 1999-03-11 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
| JP4303883B2 (ja) | 1997-09-18 | 2009-07-29 | ジェネンテック・インコーポレーテッド | ＤｃＲ３ポリペプチドというＴＮＦＲ相同体 |
| EP1021542B1 (en) | 1997-10-10 | 2009-03-04 | Genentech, Inc. | Apo-3 ligand |
| US20020072089A1 (en) | 1999-11-23 | 2002-06-13 | Holtzman Douglas A. | Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| US6046381A (en) * | 1998-04-30 | 2000-04-04 | The Regents Of The University Of California | Apolipoprotein E transgenic mice and assay methods |
| WO1999059614A1 (en) | 1998-05-20 | 1999-11-25 | Yale University | Modulation of angiogenesis and wound healing |
| EP1080194A2 (en) | 1998-05-29 | 2001-03-07 | Incyte Pharmaceuticals, Inc. | Human transmembrane proteins |
| CA2345382A1 (en) | 1998-10-16 | 2000-04-27 | Immunex Corporation | Inhibitors of platelet activation and recruitment |
| AU776910B2 (en) | 1998-12-08 | 2004-09-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Modifying protein immunogenicity |
| ES2327785T3 (es) | 1998-12-22 | 2009-11-03 | Genentech, Inc. | Procedimientos y compuestos para inhibir el crecimiento de celulas neoplasticas. |
| MXPA01007163A (es) | 1999-01-15 | 2002-03-27 | Biogen Inc | Antagonistas de tweak y de receptores de tweak y su uso para tratar trastornos inmunologicos. |
| US20020004041A1 (en) | 1999-02-19 | 2002-01-10 | Albert Matthew L. | Methods for abrogating a cellular immune response |
| PT1626058E (pt) | 1999-03-08 | 2008-02-15 | Genentech Inc | Composições e métodos para o diagnóstico de tumores |
| US6521424B2 (en) | 1999-06-07 | 2003-02-18 | Immunex Corporation | Recombinant expression of Tek antagonists |
| KR100510795B1 (en) | 1999-08-31 | 2005-08-30 | Compositions and Methods for the Treatment of Tumor | |
| US7495086B2 (en) | 1999-12-20 | 2009-02-24 | Immunex Corporation | TWEAK receptor |
| EP2298333A3 (en) * | 1999-12-20 | 2012-05-02 | Immunex Corporation | Tweak receptor |
| US6727225B2 (en) | 1999-12-20 | 2004-04-27 | Immunex Corporation | TWEAK receptor |
| IL150571A0 (en) | 2000-01-03 | 2003-02-12 | Tr Associates L L C | Novel chimeric proteins and methods for using the same |
| US7927602B2 (en) | 2002-07-23 | 2011-04-19 | University Of Louisville Research Foundation, Inc. | Fas ligand-avidin/streptavidin fusion proteins |
| NZ521437A (en) | 2000-02-25 | 2004-04-30 | Immunex Corp | Integrin antagonists suitable as inhibitors of angiogenesis |
| AU5951901A (en) | 2000-05-08 | 2001-11-20 | Biogen Inc | Method for promoting neovascularization |
| US7498304B2 (en) | 2000-06-16 | 2009-03-03 | Curis, Inc. | Angiogenesis-modulating compositions and uses |
| US20040047854A1 (en) | 2001-07-27 | 2004-03-11 | Black Roy A. | Human disintegrin protein |
| AU8901901A (en) * | 2000-09-14 | 2002-03-26 | Biogen Inc | Tweak receptor agonists as anti-angiogenic agents background |
| US7208151B2 (en) | 2001-09-12 | 2007-04-24 | Biogen Idec Ma Inc. | Tweak receptor agonists as anti-angiogenic agents |
| JP4344519B2 (ja) | 2000-12-28 | 2009-10-14 | 旭化成ファーマ株式会社 | ＮＦ−κＢ活性化遺伝子 |
| EP1379264A4 (en) | 2001-03-21 | 2009-07-08 | Human Genome Sciences Inc | HUMAN SECRETED PROTEINS |
| US20040203083A1 (en) | 2001-04-13 | 2004-10-14 | Biosite, Inc. | Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases |
| US20040076955A1 (en) | 2001-07-03 | 2004-04-22 | Eos Biotechnology, Inc. | Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| WO2003040307A2 (en) | 2001-07-27 | 2003-05-15 | Human Genome Sciences, Inc. | Heteromultimeric tnf ligand family members |
| US20040091473A1 (en) | 2001-07-27 | 2004-05-13 | Dubose Robert F. | Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| US20030148314A1 (en) | 2001-08-01 | 2003-08-07 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
| US20040033495A1 (en) | 2001-08-03 | 2004-02-19 | Eos Biotechnology, Inc. | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| US7087225B2 (en) | 2001-08-16 | 2006-08-08 | Human Genome Sciences, Inc. | Methods and compositions for treating metabolic bone diseases relating to human endokine alpha |
| MX352180B (es) | 2002-04-09 | 2017-11-13 | Biogen Ma Inc | El uso de antagonistas de tweak para el tratamiento de condiciones relacionadas con tweak. |
| WO2004063355A2 (en) | 2003-01-10 | 2004-07-29 | Protein Design Labs, Inc. | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| WO2004065416A2 (en) | 2003-01-16 | 2004-08-05 | Genentech, Inc. | Synthetic antibody phage libraries |
| WO2004072266A2 (en) | 2003-02-13 | 2004-08-26 | Kalobios Inc. | Antibody affinity engineering by serial epitope-guided complementarity replacement |
| WO2004074506A2 (en) | 2003-02-13 | 2004-09-02 | Mergen Ltd | Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers |
| WO2004079014A2 (en) | 2003-03-04 | 2004-09-16 | Arcturus Bioscience, Inc. | Signatures of er status in breast cancer |
| DE602004006871T2 (de) | 2003-07-24 | 2008-02-07 | Amgen Inc., Thousand Oaks | Zusammensetzungen und verfahren, die multimere und oligomere lösliche fragmente des tweak-rezeptors betreffen |
| EP1566636A1 (en) | 2004-02-23 | 2005-08-24 | AXARON Bioscience AG | Use of Tweak modulators and inhibitors for the treatment of neurological conditions |
| EP1811838A4 (en) | 2004-11-08 | 2009-07-22 | Univ Maryland | TWEAK AS A THERAPEUTIC TARGET FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM IN CONNECTION WITH CEREBRAL OEDEM AND CELL DEATH |
| US7939490B2 (en) | 2004-12-13 | 2011-05-10 | University Of Maryland, Baltimore | TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death |
| WO2006089095A2 (en) | 2005-02-17 | 2006-08-24 | Biogen Idec Ma Inc. | Treating neurological disorders |
| US20090068102A1 (en) | 2005-02-17 | 2009-03-12 | Biogen Idec Ma Inc. | Treating stroke |
| EP1853312B1 (en) | 2005-03-07 | 2014-12-10 | Genentech, Inc. | Methods and compositions for modulating tweak and fn14 activity |
| CA2607697C (en) | 2005-05-10 | 2015-01-06 | Biogen Idec Ma Inc. | Treating and evaluating inflammatory disorders |
| MEP35408A (en) | 2005-05-27 | 2011-02-10 | Biogen Idec Inc | Tweak binding antibodies |
| WO2006130429A2 (en) | 2005-05-27 | 2006-12-07 | Biogen Idec Ma Inc. | Treatment of cancer |
| WO2006138219A2 (en) | 2005-06-13 | 2006-12-28 | Biogen Idec Ma Inc. | Methods of diagnosis / prognosis of inflammatory conditions |
| US20100284933A1 (en) | 2006-10-16 | 2010-11-11 | Biogen Idec Ma Inc. | Biomarkers of Multiple Sclerosis |
| MX2010012324A (es) | 2008-05-15 | 2011-01-14 | Biogen Idec Inc | Anticuerpos anti-fn14 y usos de los mismos. |
| WO2010085648A2 (en) | 2009-01-23 | 2010-07-29 | Linda Burkly C | Methods for reducing radiation-induced tissue damage |
| MX2011007936A (es) | 2009-01-30 | 2011-08-17 | Biogen Idec Inc | Metodos para regeneracion de tejido pancreatico. |
| AU2011311673B2 (en) | 2010-10-05 | 2015-09-17 | F. Hoffmann-La Roche Ag | Antibodies against human TWEAK and uses thereof |
-
2003
- 2003-04-09 MX MX2015013981A patent/MX352180B/es unknown
- 2003-04-09 SI SI200332336T patent/SI1997512T1/sl unknown
- 2003-04-09 CA CA2887716A patent/CA2887716C/en not_active Expired - Fee Related
- 2003-04-09 CN CN038133172A patent/CN1658901A/zh active Pending
- 2003-04-09 US US10/510,804 patent/US20060240004A1/en not_active Abandoned
- 2003-04-09 EP EP03721647A patent/EP1494713A4/en not_active Withdrawn
- 2003-04-09 JP JP2003583337A patent/JP2005536455A/ja active Pending
- 2003-04-09 NZ NZ536348A patent/NZ536348A/en not_active IP Right Cessation
- 2003-04-09 EA EA200401329A patent/EA011607B1/ru not_active IP Right Cessation
- 2003-04-09 CN CN201310506714.5A patent/CN103536916B/zh not_active Expired - Fee Related
- 2003-04-09 EP EP20080104327 patent/EP1997512B1/en not_active Expired - Lifetime
- 2003-04-09 EP EP20100181810 patent/EP2301578A3/en not_active Withdrawn
- 2003-04-09 KR KR20047016169A patent/KR101000842B1/ko not_active Expired - Fee Related
- 2003-04-09 KR KR1020107018497A patent/KR101174214B1/ko not_active Expired - Fee Related
- 2003-04-09 WO PCT/US2003/011350 patent/WO2003086311A2/en not_active Ceased
- 2003-04-09 AU AU2003224950A patent/AU2003224950B2/en not_active Ceased
- 2003-04-09 DK DK08104327T patent/DK1997512T3/da active
- 2003-04-09 EP EP20100181803 patent/EP2301577A3/en not_active Withdrawn
- 2003-04-09 CN CN201610471339.9A patent/CN106421778A/zh active Pending
- 2003-04-09 CA CA002480745A patent/CA2480745A1/en not_active Abandoned
- 2003-04-09 CN CN200910165731A patent/CN101683520A/zh active Pending
- 2003-04-09 BR BRPI0309126A patent/BRPI0309126A8/pt not_active Application Discontinuation
- 2003-04-09 CN CN2012102686488A patent/CN102793921A/zh active Pending
- 2003-04-09 IL IL16435203A patent/IL164352A0/xx unknown
- 2003-04-09 MX MXPA04009683A patent/MXPA04009683A/es active IP Right Grant
- 2003-04-09 PT PT08104327T patent/PT1997512E/pt unknown
- 2003-04-09 ES ES08104327T patent/ES2444121T3/es not_active Expired - Lifetime
- 2003-04-09 NZ NZ548701A patent/NZ548701A/en not_active IP Right Cessation
-
2004
- 2004-09-28 IL IL164352A patent/IL164352A/en active IP Right Grant
- 2004-10-06 ZA ZA200408073A patent/ZA200408073B/en unknown
- 2004-11-08 NO NO20044857A patent/NO334266B1/no not_active IP Right Cessation
-
2009
- 2009-04-03 US US12/417,755 patent/US8506958B2/en not_active Expired - Fee Related
- 2009-09-01 JP JP2009202035A patent/JP5603040B2/ja not_active Expired - Fee Related
-
2011
- 2011-07-08 US US13/179,096 patent/US20120015024A1/en not_active Abandoned
- 2011-09-08 JP JP2011196571A patent/JP2012021014A/ja not_active Withdrawn
-
2013
- 2013-04-11 US US13/860,983 patent/US9011859B2/en not_active Expired - Fee Related
- 2013-12-06 NO NO20131617A patent/NO338778B1/no not_active IP Right Cessation
- 2013-12-25 IL IL230158A patent/IL230158B/en active IP Right Grant
-
2014
- 2014-01-31 JP JP2014016608A patent/JP5916776B2/ja not_active Expired - Fee Related
-
2015
- 2015-03-18 US US14/661,391 patent/US20150291688A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009286793A5 (https=) | ||
| ES2747573T3 (es) | Anticuerpos anti-IL-12, composiciones, métodos y usos para tratar la patología de Crohn | |
| RS51197B (sr) | Anti-dual integrinska antitela, sastavi, metode i njihove upotrebe | |
| US11993645B2 (en) | Compositions comprising R-Spondin (RSPO) surrogate molecules | |
| KR20190031259A (ko) | 결합 단백질-소분자 콘주게이트의 ev-매개 전달 | |
| JP2018513384A (ja) | Ｒｏｒ１−ｒｏｒ２結合のモジュレーター | |
| JP2012508163A5 (https=) | ||
| JP2011130770A5 (https=) | ||
| ES2926511T3 (es) | Anticuerpos anti-CLEVER-1 humanizados y utilización de los mismos | |
| AU2001281137A1 (en) | Anti-il-12 antibodies, compositions, methods and uses | |
| TW201444866A (zh) | 針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法 | |
| TW201408298A (zh) | 免疫相關及發炎疾病之治療 | |
| JP2013535436A5 (https=) | ||
| US20120020913A1 (en) | Methods for pancreatic tissue regeneration | |
| CN106255706A (zh) | TATk‑CDKL5融合蛋白、其组合物、配制品以及用途 | |
| US20140255426A1 (en) | Wnt pathway inhibitors for treating viral infections | |
| JP2019505565A (ja) | 新規の抗血管新生融合ポリペプチド | |
| WO2011126882A2 (en) | Therapeutic peptides and their derivatives and therapeutic uses thereof | |
| Chen et al. | Biomolecular Condensates Based on Amino Acid for Enhancing Oral Bioavailability and Therapeutic Efficacy of Hydrophobic Drugs | |
| EP1814579A2 (fr) | Netrine 4 mutee, ses fragments et leur utilisation comme medicaments | |
| KR20240021227A (ko) | 방사성면역접합체와 체크포인트 억제제의 조합 요법 | |
| Greco et al. | CART Cells and Other Cell Therapies (ie MSC, Tregs) in Autoimmune Diseases | |
| TWI329672B (en) | Anti-il-12 sntibodies, compositions, method and uses | |
| JP2025530992A (ja) | 形質細胞様樹状細胞の枯渇および阻害 | |
| WO2015188126A1 (en) | Compositions and methods for treating tumors and immune based inflammatory diseases |